@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix ns1: <https://w3id.org/np/o/ntemplate/> .
@prefix this: <http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik> .
@prefix sub: <http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_10763> biolink:category biolink:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_10763>;
    rdf:predicate biolink:treats;
    rdf:subject <https://identifiers.org/drugbank:DB00701>;
    a rdf:Statement;
    rdfs:label "\"*     [see Drug Interactions ( 7 12.3      * LEXIVA is contraindicated when coadministered with the following drugs:  o Alpha 1-adrenoreceptor antagonist: Alfuzosin  o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir)  o Antimycobacterial: Rifampin  o Antipsychotic: Lurasidone (with ritonavir), pimozide  o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine  o GI motility agent: Cisapride  o Herbal product: St. John's wort ( Hypericum perforatum    o Lipid modifying agents: Lomitapide, lovastatin, simvastatin  o Non-nucleoside reverse transcriptase inhibitor: Delavirdine  o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension)  o Sedative/hypnotics: Midazolam, triazolam     * 4   * 4   * 4\"";
    biolink:provided_by <https://w3id.org/um/NeuroDKG>;
    biolink:relation schema:MedicalContraindication .
  
  <https://identifiers.org/drugbank:DB00701> biolink:category biolink:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "KbmORKHgOhdE4yYyClv95x8Ra0oBPSaXPdTeZSYXns62laEFVYQX9M+SArGkgBvk9+wS/lBE2zfQuRRy+6/B8wOuW02F/U6FEJ1IlLlqWoxxK6Qiz3digzHoCV17AExW38CW827p/CluSJpEd9FwzxM2z5c30UxA8/kS9PpRp6k=";
    npx:hasSignatureTarget this: .
  
  this: dct:created "2021-08-23T18:36:07.853+02:00"^^xsd:dateTime;
    dct:creator orcid:0000-0002-1468-3557;
    ns1:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    ns1:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    ns1:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}